Abstract
H. pylori is a bacterium which colonizes the gastric mucosa. In 1896, Salomon described spiral organisms in stomachs of man and animals [1]. It was not until 1983, when Warren and Marshall first reported the isolation of a spiral bacterium from gastric biopsies of patients with gastritis [2, 3], that the dramatic expansion of information on H. pylori (Hp) began. Its worldwide distribution and high prevalence make it one of the commonest infections in mankind [4, 5]. Hp infection is associated with chronic type B gastritis, duodenal and gastric ulcer, and gastric carcinoma [6, 7] (Tables 1 and 2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Salomon H (1896) Ueber das Spirillum des Saugetiermagens und sein Verhalten zu den Belegzellen. Zentralbl Bakt (Naturwiss) 19: 433–443
Warren JR, Marshall B (1983) Unidentified cured bacilli on gastric epithelium in active chronic gastritis. Lancet i: 1273
Marshall BJ (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet ii: 1273–1275
Goodwin CS, Armstrong JA, Marshall BJ (1986) Campylobacter pyloridis, gastritis and peptic ulceration. J Clin Pathol 39: 353–365
Graham DY, Klein PD, Opekun AR, Boutton TW (1988) Effect of age on the frequency of active Campylobacter pyloridis infection diagnosed by the [13C] urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis 157: 7777–7780
Blaser MJ (1990) H. pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161: 626–633
Tytgat GNJ, Rauws EAJ, De Koster E (1988) Campylobacter pylori. Scand J Gastroenterol 155 (suppl): 68–81.
Morris A, Nicholson G (1989) Experimental and accidental C. pylori infection of humans. In: Blaser MJ (ed) Campylobacter pylori in gastritis and peptic ulcer disease. Igaku-Shoin, New York, pp 61–72
Sipponen P, Kosunen TU, Valle J, Riihela, Seppala K (1992) H. pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 45: 319–323
Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ (1991) H. pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325: 1132–1136
Talley NJ, Zinsmeister AR, DiMagno EP, Weaver A, Carpenter HA, Perez-Perez GI, Blaser MJ (1991) Gastric adenocarcinoma and H. pylori infection. J Natl Cancer Inst 83: 1734–1739
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley (1991) H. pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127 - 1131
Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, Sitas F (1991) Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302: 1302–1305
Slomiany BL, Bilski J, Sarosiek J et al. (1987) Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun 144: 307–314
Slomiany BL, Nishikawa H, Piotrowski J et al. (1989) Lipolytic activity of Campylobacter pylori: effect of sofalcone. Digestion 43: 33–40
Yuonan F, Pearson J, Allen A et al. (1982) Changes in the structure of the mucus gel on the mucosal surface of the stomach in association with peptic ulcer. Gastroenterology 82: 817–831
Slomiany BL, Slomiany A (1991) Role of mucus in gastric mucosal protection. J Physiol Pharmacol 42: 149–163
Slomiany BL, Kasinathan C, Slomiany A (1989) Effect of colloidal bismuth subcitrate on the lipolytic activity of Campylobacter pylori. Gastroenterol 84: 1273–1277
Sidebotham RL, Baron JH (1990) Hypothesis: H. pylori, urease, mucus, and gastric ulcer. Lancet 335: 193–195
Morris A, Maher K, Thomsen L, Miller M, Nicholson G, Tasman-Jones C (1988) Distribution of Campylobacter pylori in the human stomach obtained at postmortem. Scand J Gastroenterol 23: 257–264
Hazel I SL, Hennessy WB, Borody TJ, Carrick J, Ralston M, Brady L, Lee A (1987) Campylobacter pyloridis gastritis II: distribution of bacteria and associated inflammation in the gastroduodenal environment. Am J Gastroenterol 82: 297–301
Back GE, Gourley WK, Lee WK et al. (1986) Relation of Campylobacter pyloridis to gastritis and peptic ulcer. J Infect Dis 153: 664–669
Price AB, Levi J, Dolby JM et al. (1985) Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut 26: 1183–1188
Satoh K, Kimura K, Yoshida Y, Kasano T, Kihira K, Taniguchi Y (1991) A topographical relationship between H. pylori and gastritis: Quantitative assessment of H. pylori in the gastric mucosa. Amer J Gastroenterol 86: 285–291
Karttunen T, Niemela S, Lehtola J et. al (1987) Campylobacter-like organisms and gastritis: Histopathology, bile reflux, and gastric fluid composition. Scand J Gastroenterol 22: 478–486
Queiroz DMM, Barbosa A J A, Nendes EN et al. (1988) Distribution of Campylobacter pylori and gastritis in the stomach of patients with and without duodenal ulcer. Am J Gastroenterol 83: 1368–1370
Bayerdorffer E, Oertel H, Lehn N et al. (1989) Topographical association between active gastritis and Campylobacter pylori colonization. J Clin Pathol 42: 834–839
Stolte M, Eidt S. Ohnsmann A (1990) Differences in H. pylori-associated gastritis in the antrum and body of the stomach. Z. Gastroenterol 28: 229–233
Steininger H, Schneider U, Bartz K, Simmler B (1989) Campylobacter pylori und Gastritis — Besiedelungsdichte und Grad der Entzündung. Semiquantitative und morphometrische Untersuchung. Leber Magen Darm 19: 70–78
Collins JSA, Sloan JM, Hamilton PW, Watt PCH, Love AHG (1989) Investigation of the relationship between gastric antral inflammation and Campylobacter pylori using graphic tablet planimetry. J Pathol 158: 281–285
Goodwin CS, Armstrong JA, Marshall BK (1986) Campylobacter pyloridis gastritis and peptic ulcerations. J Clin Pathol 39: 353–365
Siurala M, Varis K, Wiljasalo M (1966) Studies of patients with atrophic gastritis: a 10–15 year follow up. Scand J Gastroenterol 1: 40–48
Siurala M, Isokoski M, Varis K, Kekki M (1968) Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random. Scand J Gastroenterol 3: 211–223
Dooley CP, Cohen H, Fitzgibbons PL, Mauer M, Appleman MD, Perez-Perez GI, Blaser MJ (1989) Prevalence of H. pylori infection and histologic gastritis in asymptomatic ons. N Engl J Med 321: 1562–1566
Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320: 365–376
Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI (1991) Mucosal tumour necrosis factor a and interleukin-6 in patients with H. pylori associated gastritis. Gut 32: 1473–1477
Engstrand L, Scheynius A, Pahlson C, Grimelius L, Schwan A, Gustavsson S (1989) Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun 57: 827–832
Mai UEH, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD (1991) Soluble surface proteins from H. pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 87: 894–900
Steinbeck MJ, Roth JA (1989) Neutrophil activation by recombinant cytokines. Rev Infect Dis 11: 549–568
Papadimitriou CS, Iaachim-Velogianni EE, Tsianos EB, Moutsopoulos HM (1988) Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis. Virchows Arch (A) 413: 197–204
Lambert JR, Borromeo M, Korman MG, Hansky J (1987) Role of Campylobacter pyloridis in non-ulcer dyspepsia. A randomized controlled trial. Gastroenterology 91: 1488
Rathbone BJ, Wyatt JI, Worsley BW, Shires SE, Trejdosiewicz LK, Heatley RV, Losowsky MS (1986) Systemic and local antibody responses to Campylobacter pyloridis in non-ulcer dyspepsia. Gut 27: M2 - 647
Rathbone BJ, Heatley RV (1989) Immunology of C. pylori infection. In: Blaser MJ (ed.) Campylobacter pylori in gastritis and peptic ulcer disease. Igaku Shoin, New York pp 135–140
Hessey SJ, Spencer J, Wyatt JL et al. (1990) Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 31: 134–138
Smoot DT, Mobley HLR, Gillian T et al. (1989) Pedestal formation of H. pylori with gastric epithelial cells in vitro may require actin polymerization. Gastroenterology 5: A127
Evans DJ, Evans DG, Smith KE, Graham DY (1989) Serum antibody responses to the N-acetylneuraminyllactose-binding hemagglutinin of Cambylobacter pylori. Infect Immun 57: 664–667
Wyle FA, Tarnawski A, Wadington S (1990) Pathogenesis of H. pylori gastric disease: the role of adherence. Amer J Gastroent 85: 1243
Hui PK, Chan WY, Cheung PS, Chan JK, Ng CS (1992) Pathologic changes of gastric mucosa colonized by H. pylori. Hum Pathol 23: 548–556
Kazi JL, Sinniah R, Zaman V, Ng ML, Jafarey NA, Alam SM, Zuberi SJ, Kazi AM (1990) Ultrastructural study of H. pylori-associated gastritis. J Pathol 161: 65–70
Hazell SL, Lee A, Brady L, Hennessy W (1986) Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptations to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 153: 658–663
Chen XG, Correa P, Offerhaus J et al. (1986) Ultrastructure of the gastric mucosa harboring Campylobacter like organisms. Am J Clin Pathol 86: 575–582
Bode G, Malfertheiner P, Ditschneit H (1988) Pathogenetic implications of ultrastructural finding in C. pylori related gastroduodenal disease. Scand J Gastroenterol 23: 25–39
Wyle FA, Tarnawski A, Schulman D, Dabros W (1990) Evidence for gastric mucosal cell invasion by C. pylori: an ultrastructural study. J Clin Gastroent 12 (suppl 1): 92–98
Dick JD (1990) Helicobacter (Campylobacter) priori priori: a new twist to an old disease. Annu Rev Microbiol 44: 249–269
Rauws EAJ, Tytgat GNJ (1989) Campylobacter pylori. WC den Ouden, Amsterdam
Blaser MJ (1990) Epidemiology and pathophysiology of Campylobacter pylori infections. Rev Infect Dis 12 (suppl 1): 4–4–59
Smoot DT, Mobley HLT, Chippendale GR, Lewison JF, Resau JH (1990) Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun 58: 1992–1994
Johnson WM, Lior H (1986) Production of heat-labile cytotoxin by Campylobacter pyloridis. Adv Intern Med 34: B234
Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR (1988) Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med Microbiol 26: 93–99
Leunk RD (1991) Production of a cytotoxin by H. pylori. Rev Infect Dis 13 (suppl 8): S686–689
Cover TL, Puryear W, Perez-Perez GI, Blaser MJ (1991) Effect of urease on HeLa cell vacuolation induced by H. pylori cytotoxin. Infect Immun 59: 1264–1270
Cover TL, Blaser MJ (1992) Purification and characterization of the vacuolating toxin from H. pylori. J Biol Chem 267: 10570–10575
Cover TL, Dooley CP, Blaser MJ (1990) Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 58: 603–610
Guerrant RI, Barrett LJ, Marshall BJ (1991) Cytotoxin production by Campylobacter pylori. In: Ruiz-Palacios G (ed.) Campylobacter V. Mexico City, Instituto Nacional de la Nutricion
Eaton KA, Morgan DR, Krakowka S. (1989) Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun 57: 1119–1125
Tricottet V, Bruneval P, Vire O, Camilleri JP, Bloch R, Bonte N, Roge J (1986) Campylobacter- like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study. Ultrastruct Pathol 10: 113–122
Leunk RD, Ferguson MA, Morgan DR, Low DE, Simor AE (1990) Antibody to cytotoxin in infection by H. pylori. J Clin Microbiol 28: 1181–1184
Cover TL, Cao P, Blaser MJ (1991) Neutralization of H. pylori cytotoxin-induced HeLa cell vacuolation by human sera. Gastroenterology 100: A570
Chang K, Fujiwara Y, Wyle F, Tarnawski A (1992) H. pylori toxin inhibits growth and proliferation of cultured gastric cells — Kato III. J Phys Pharm (in press)
Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, Russi M, Quaranta S (1989) Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 27: 225–226
Slomiany BL, Kasinathan C and Slomiany A (1989) Lipolytic activity of Campylobacter pylori: effect of colloidal bismuth subcitrate (De-No 1). Amer J Gastroent 84: 1273–1277
Langton SR, Cesaarco SD (1992) H. pylori associated phospholipase A2 activity: a factor in peptic ulcer production? J Clin Pathol 45: 221–224
Raedsch R, Stiehl A, Waldherr R, Pasch B, Kommereil B (1988) Elevated concentrations of not amidated and secondary bile acids and lysolecithin in gastric juice in the presence of Campylobacter pylori. Gastroenterology 94: A257
Denizot Y, Sobhani I, Rambaud JC, Lewin M, Thomas Y, Benveniste J (1990) PAF-acether synthesis by H. pylori. Gut 31: 1242–1245
Rosam AC, Wallace JL, Whitde BJR (1990) Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature 319: 54–56
Wallace JL, Whittle BJR (1986) Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. Prostaglandins 31: 989–998
Levi S, Beardshell K, Haddad G, Playford R, Ghosh P, Calam J (1989) Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1: 1167–1168
Smith JTL, Pounder RE, Evans DJ, Graham DY, Evans DG (1989) Inappropriate 24 hour hypergastrinemia in asymptomatic C. pylori infection. Gut 30: A732 - A733
Karnes WE, Ohning GV, Sytnik B, Kim SWR, Walsh JH (1991) Preservation of pH inhibition of gastrin release in subjects with H. pylori. Rev Infect Dis 13: S665 - S670
Graham DY, Opekun A, Lew GM, Evans Jr DJ, Klein PD, Evans DG (1990) Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of H. ( Campylobacter) pylori infection. Am J Gastoenterol 85: 394–398
Samloff IM (1989) Peptic ulcer: The many proteinases of aggression. Gastroenterology 96 (suppl): 586–595
Veenendaal RA, Biemond I, Pena AS, van Duijn W, Kreuning J, Lames CBHW. (1992) Influence of age and H. pylori infection on serum pepsinogens in healthy blood transfusion donors. Gut 33: 452–455
Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, Miki K, Graham DY (1992) Relationship of H. pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102: 760–766
Oderda G, Vaira D, Holton J, Dowsett JF, Ansaldi N (1989) Serum eosinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood. Gut 30: 912–916
Samoff IM, Varis K, Ihamaki T, Siurala M, Rotter JI (1982) Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 83: 204–209
Westerveld BB, Pals G, Lamers CBHW, Defize J, Pronk JC, Frants RR (1987) Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 59: 952–958
Wyle FA, Chang KJ (1993) H. pylori: are they different from one another/? Eur J Gastroent Hep (in press)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wyle, F.A., Chang, K.J., Tarnawski, A. (1993). Helicobacter pylori: Pathogenic Mechanisms. In: Domschke, W., Konturek, S.J. (eds) The Stomach. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78176-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-78176-6_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56613-7
Online ISBN: 978-3-642-78176-6
eBook Packages: Springer Book Archive